Number of the records: 1  

The transcription factor EGR1 regulates metastatic potential of v-src transformed sarcoma cells

  1. 1.
    SYSNO ASEP0347089
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JČlánek ve WOS
    TitleThe transcription factor EGR1 regulates metastatic potential of v-src transformed sarcoma cells
    Author(s) Čermák, Vladimír (UMG-J)
    Kosla, Jan (UMG-J) RID
    Plachý, Jiří (UMG-J) RID
    Trejbalová, Kateřina (UMG-J) RID
    Hejnar, Jiří (UMG-J) RID
    Dvořák, Michal (UMG-J) RID
    Source TitleCellular and Molecular Life Sciences - ISSN 1420-682X
    Roč. 67, č. 20 (2010), s. 3557-3568
    Number of pages12 s.
    Languageeng - English
    CountryCH - Switzerland
    Keywordssmooth muscle cells ; endothelial kinase ; Rho kinase
    Subject RIVEB - Genetics ; Molecular Biology
    R&D ProjectsKAN200520801 GA AV ČR - Academy of Sciences of the Czech Republic (AV ČR)
    LC06061 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
    GA204/07/1030 GA ČR - Czech Science Foundation (CSF)
    CEZAV0Z50520514 - UMG-J (2005-2011)
    UT WOS000282045900013
    DOI10.1007/s00018-010-0395-6
    AnnotationTo advance our understanding of metastatic cancer dissemination, we have developed a model system that is based on two v-src transformed chicken sarcoma cell lines-the highly metastatic parental PR9692 and a non-metastasizing but fully tumorigenic clonal derivative PR9692-E9. Oligonucleotide microarray analysis of both cell lines revealed that the gene encoding the transcription factor EGR1 was downregulated in the non-metastatic PR9692-E9 cells. Further investigation demonstrated that the introduction of exogenous EGR1 into PR9692-E9 cells restored their metastatic potential to a level indistinguishable from parental PR9692 cells. Microarray analysis of EGR1 reconstituted cells revealed the activation of genes that are crucial for actin cytoskeleton contractility (MYL9), filopodia formation (MYO10), the production of specific extracellular matrix components (HAS2, COL6A1-3) and other essential pro-metastatic abilities.
    WorkplaceInstitute of Molecular Genetics
    ContactNikol Škňouřilová, nikol.sknourilova@img.cas.cz, Tel.: 241 063 217
    Year of Publishing2011
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.